article thumbnail

News Release Benchmarks for Healthcare & BioTechnology

Onclusive

In a first-of-its kind research study, we analyzed 15,000 press releases across two dozen industries to better understand how they affect generating syndicated pick-up, social media engagement, and editorial coverage. In 2019, Onclusive and Business Wire teamed up to identify the characteristics of a winning news release. Business Wire.

article thumbnail

How to Make your Messaging Stick

Onclusive

23andMe , a personal genomics and biotechnology leader, used NEO during a recent campaign launch to look at the key messages and terms that were driving the most website traffic and actions. Read the full case study. Read the full case study. Read the full case study. Know how well your messaging works.

How To 370
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Stop Smearing Goldfish: That Attention Span Statistic is Dubious

Sword and the Script

The statistic goes like this: A 2015 Microsoft study shows that the average consumer has an attention span of eight seconds down from 12 seconds back in 2000. The piece goes on to interview a psychologist who “studies attention in drivers and witnesses to crime.” What does the study say? That goldfish statistic just won’t die.

article thumbnail

The Anatomy of Attention

Doctor Spin

A recent study published in the National Center for Biotechnology Information highlights this trend, emphasizing how the multitude of online media sources vies for our attention, often at the expense of our ability to concentrate for extended periods. 2 Firth, J., 3 Abundance of information narrows our collective attention span.

eBook 52
article thumbnail

Women in Tech: Closing the Gap, One Byte at a Time

Stern + Associates

government, multinational companies and global entities such as the World Health Organization – examine complex legal, ethical and regulatory issues surrounding biotechnology and emerging sciences. For decades, acclaimed bioethicist, futurist and legal scholar Alta Charo has been helping organizations – including the U.S.